oxidopamine has been researched along with Glaucoma, Suspect in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin and its analogue, 5-methoxycarbonylamino-N-acetyltryptamine (5-MCA-NAT), potently reduce intraocular pressure, and may be good candidates for the treatment of ocular hypertension and glaucoma." | 3.74 | Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT. ( Alarma-Estrany, P; Crooke, A; Peral, A; Pintor, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alarma-Estrany, P | 1 |
| Crooke, A | 1 |
| Peral, A | 1 |
| Pintor, J | 1 |
1 other study available for oxidopamine and Glaucoma, Suspect
| Article | Year |
|---|---|
Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT.
Topics: Adrenergic Uptake Inhibitors; Animals; Central Nervous System Depressants; Dose-Response Relationshi | 2007 |